Literature DB >> 11705993

The activated glucocorticoid receptor modulates presumptive autoregulation of ribosomal protein S6 protein kinase, p70 S6K.

O Jameel Shah1, Jorge A Iniguez-Lluhi, Angela Romanelli, Scot R Kimball, Leonard S Jefferson.   

Abstract

Protein metabolism in eukaryotic organisms is defined by a synthesis-degradation equilibrium that is subject to regulation by hormonal and nutritional signals. In mammalian tissues such as skeletal muscle, glucocorticoid hormones specify a catabolic response that influences both protein synthetic and protein degradative pathways. With regard to the former, glucocorticoids attenuate mRNA translation at two levels: translational efficiency, i.e. translation initiation, and translational capacity, i.e. ribosome biogenesis. Glucocorticoids may impair translational capacity through the ribosomal S6 protein kinase (p70 S6K), a recognized glucocorticoid target and an effector of ribosomal protein synthesis. We demonstrate here that the reduction in growth factor-activated p70 S6K activity by glucocorticoids depends upon a functional glucocorticoid receptor (GR) and that the GR is both necessary and sufficient to render p70 S6K subject to glucocorticoid regulation. Furthermore, the DNA binding and transcriptional activation but not repression properties of the GR are indispensable for p70 S6K regulation. Finally, a mutational analysis of the p70 S6K carboxyl terminus indicates that this region confers glucocorticoid sensitivity, and thus glucocorticoids may facilitate autoinhibition of the enzyme ultimately reducing the efficiency with which T389 is phosphorylated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11705993     DOI: 10.1074/jbc.M105935200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Control of translation initiation through integration of signals generated by hormones, nutrients, and exercise.

Authors:  Scot R Kimball; Leonard S Jefferson
Journal:  J Biol Chem       Date:  2010-06-24       Impact factor: 5.157

Review 2.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

3.  Betaine supplementation enhances anabolic endocrine and Akt signaling in response to acute bouts of exercise.

Authors:  Jenna M Apicella; Elaine C Lee; Brooke L Bailey; Catherine Saenz; Jeffrey M Anderson; Stuart A S Craig; William J Kraemer; Jeff S Volek; Carl M Maresh
Journal:  Eur J Appl Physiol       Date:  2012-09-14       Impact factor: 3.078

4.  Studying mechanisms of cAMP and cyclic nucleotide phosphodiesterase signaling in Leydig cell function with phosphoproteomics.

Authors:  Martin Golkowski; Masami Shimizu-Albergine; Hyong Won Suh; Joseph A Beavo; Shao-En Ong
Journal:  Cell Signal       Date:  2015-11-28       Impact factor: 4.315

Review 5.  Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease.

Authors:  Valerie I Brown; Alix E Seif; Gregor S D Reid; David T Teachey; Stephan A Grupp
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

6.  A clinically relevant decrease in contractile force differentially regulates control of glucocorticoid receptor translocation in mouse skeletal muscle.

Authors:  Kirsten R Dunlap; Jennifer L Steiner; Michael L Rossetti; Scot R Kimball; Bradley S Gordon
Journal:  J Appl Physiol (1985)       Date:  2021-02-18

7.  EGF-induced activation of Akt results in mTOR-dependent p70S6 kinase phosphorylation and inhibition of HC11 cell lactogenic differentiation.

Authors:  Traci Galbaugh; Maria Grazia Cerrito; Cynthia C Jose; Mary Lou Cutler
Journal:  BMC Cell Biol       Date:  2006-09-19       Impact factor: 4.241

8.  IRES-mediated translation of utrophin A is enhanced by glucocorticoid treatment in skeletal muscle cells.

Authors:  Pedro Miura; Meghan Andrews; Martin Holcik; Bernard J Jasmin
Journal:  PLoS One       Date:  2008-06-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.